Autotaxin – A Target for the Treatment of Drug-Resistant Ovarian Cancer?

QR Code

Autotaxin – A Target for the Treatment of Drug-Resistant Ovarian Cancer?

None

Saved in:

Bibliographic Details
Main Authors:	King-Underwood, John, Allin, Steven M., Redman, Charles W., Richardson, Alan
Format:	Electronic Book Chapter
Language:	English
Published:	IntechOpen 2012
Subjects:	Health Sciences
Online Access:	https://www.intechopen.com/chapters/28410
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The critical role and potential target of the autotaxin/lysophosphatidate axis in pancreatic cancer
by: Ming Quan, et al.
Published: (2017-03-01)

Role of inflammation, autotaxin and lipoprotein (a) in degenerative aortic valve stenosis in patients with coronary artery disease
by: A. L. Burdeynaya, et al.
Published: (2021-03-01)

ERCC1 as a Marker of Ovarian Cancer Resistance to Platinum Drugs
by: T. A. Bogush, et al.
Published: (2020-05-01)

VEGF Targeting Agents in Ovarian Cancer
by: Mabuchi, Seiji, et al.
Published: (2012)

Exosomes in ovarian cancer: Impact on drug resistance and advances in SERS detection techniques
by: Biqing Chen, et al.
Published: (2025-07-01)

Hydrogen Sulfide Expression May Affect Ovarian Cancer Progression and Drug Resistance
by: Zhu Q, et al.
Published: (2025-05-01)

Targeting drug resistant colorectal cancer with apigenin nanoarchitectures
by: Pouya Goleij, et al.
Published: (2025-09-01)

The leadership of topotecan in the treatment of recurrent platinum-resistant ovarian cancer
by: K. E. Borisov
Published: (2014-07-01)

Target therapy of ovarian cancer: hardship and progress
by: PRESS RELEASE
Published: (2014-08-01)

RETRACTED ARTICLE: Nanoscale drug delivery strategies for therapy of ovarian cancer: conventional vs targeted
by: Swati Gupta, et al.
Published: (2019-12-01)

Progress of targeted FOX family therapy in ovarian cancer
by: Hairong Zhang, et al.
Published: (2025-07-01)

Ferroptosis by nanomaterials: targeting cancer stem cells and overcoming drug resistance
by: Xiaoman Wang, et al.
Published: (2025-04-01)

The impact of parity, infertility and treatment with fertility drugs on the risk of ovarian cancer: A survey
by: Berit Jul Mosgaard, et al.
Published: (1997-02-01)

Immunosuppressive mechanisms and therapeutic targeting of regulatory T cells in ovarian cancer
by: Jing Li, et al.
Published: (2025-07-01)

NANO-DRUG DESIGNING STRATEGIES AND TARGETED APPLICATIONS FOR CANCER TREATMENT
by: Umar Noor, et al.
Published: (2023-03-01)

Comparative Analysis between Two Anticancer Drugs: Platinum Complexes and Camptothecin in Ovarian Cancer Treatment
by: Zhou Yuhan
Published: (2025-01-01)

Immunotherapy for Platinum-Resistant Ovarian Cancer as a Glimmer of Hope
by: Jan Brancewicz, et al.
Published: (2025-06-01)

NEW TRENDS IN THE TREATMENT OF ADVANCED OVARIAN CANCER
by: S. V. Khohlova
Published: (2014-09-01)

A new view of treatment for ovarian cancer
by: S. V. Khokhlova
Published: (2014-08-01)

Operational considerations of select new treatment recommendations for drug-susceptible and drug-resistant tuberculosis
by: John W. Wilson, et al.
Published: (2025-08-01)

Hereditary breast cancer and ovarian cancer: clinical course and treatment
by: V. V. Semiglazov, et al.
Published: (2021-03-01)

Potential Monoclonal Antibody Therapy for the Treatment of Ovarian Cancer
by: Lee, Gregory, et al.
Published: (2012)

Optimizing the primary treatment of patients with advanced ovarian cancer
by: S. O. Nikogosyan, et al.
Published: (2016-11-01)

ULTRASOUND PROGNOSTIC CRITERIA OF THE EFFICIENCY OF OVARIAN CANCER TREATMENT
by: A. D. Zubov, et al.
Published: (2016-08-01)

DISSEMINATED OVARIAN CANCER: SURGICAL TREATMENT (LITERATURE REVIEW)
by: S. V. Molchanov, et al.
Published: (2016-02-01)

DISSEMINATED OVARIAN CANCER: MODERN APPROACH TO DRUG THERAPY (REVIEW OF PUBLISHED LITERATURE)
by: S. V. Molchanov, et al.
Published: (2016-02-01)

Folate Receptor, Trop 2, Ovarian Cancer, and Antibody-Drug Conjugate (ADC)
by: Chinmoy K. Bose, et al.
Published: (2025-08-01)

Immunohistochemical parameters of serous ovarian carcinomas and possible mechanism of development of resistance to platinum-based drugs
by: G. V. Zhukova, et al.
Published: (2024-09-01)

HERV-derived epitopes represent new targets for T-cell-based immunotherapies in ovarian cancer
by: Qing Wang, et al.
Published: (2025-08-01)

Cell Cycle Regulatory Proteins in Breast Cancer: Molecular Determinants of Drug Resistance and Targets for Anticancer Therapies
by: Ahmad, Aamir, et al.
Published: (2012)

Inflammation and Ovarian Cancer
by: Macciò, Antonio, et al.
Published: (2012)

Hereditary ovarian cancer
by: Kh. B. Kotiv, et al.
Published: (2022-11-01)

Cyclooxygenases and Lipoxygenases in Cancer Drug Resistance
by: Hasan Hüseyin Kazan, et al.
Published: (2025-07-01)

Advancements in polycaprolactone nanoparticles for targeted drug delivery in breast cancer treatment: Strategies and challenges
by: Kashyak L. Sahu, et al.
Published: (2025-01-01)

Treatment of Ovarian Clear Cell Carcinoma: A Case of Successful Management With Targeted Therapies
by: Sydney Pence, et al.
Published: (2025-01-01)

Molecular biological and ultrasonic methods in the evaluation of the effectiveness of drug therapy in patients with cervical cancer and ovarian cancer
by: L. A. Ashrafyan, et al.
Published: (2014-07-01)

Cytoreductive HIPEC-Combined Surgery in Treatment of Advanced Ovarian Cancer
by: M. V. Zabelin, et al.
Published: (2022-06-01)

Vascular endothelial growth factor inhibitors in the treatment of ovarian cancer
by: S. V. Khokhlova
Published: (2014-08-01)

Impact of hyperbaric oxygenation on the efficiency of combined treatment for ovarian cancer
by: A. S. Dzasokhov
Published: (2014-07-01)

Experience of using chemotherapy treatment for the first recurrence of ovarian cancer
by: V. N. Zhurman
Published: (2025-01-01)